HAVCR2 and classic Hodgkin lymphoma: In univariate analysis, high TIM-3 expression in non-tumor components was associated with shortened progression-free survival (PFS) of cHL patients (hazard ratio 3.28, 95% CI 1.34–8.00, log rank p-value = 0.006).